ETF · holdings as filed 2026-04-30

What's inside ARKG?

ARK Genomic Revolution ETF

Holdings

positions in the fund

Top 10

59%

of fund assets

Expense ratio

0.75%

net, per year

Fund size

$1B

total net assets

Top 15 holdings

TEMTEMPUS AI INC-CL A

9.42%

TWSTTWIST BIOSCIENCE CORP

8.99%

CRSPCRISPR THERAPEUTICS AG

8.91%

TXG10X GENOMICS INC-CLASS A

5.77%

BEAMBEAM THERAPEUTICS INC

5.43%

ABSIABSCI CORP

4.78%

NTRANATERA INC

4.07%

ILMNILLUMINA INC

4.03%

NTLAINTELLIA THERAPEUTICS INC

3.82%

PSNLPERSONALIS INC

3.58%

RXRXRECURSION PHARMACEUTICALS-A

3.51%

GHGUARDANT HEALTH INC

3.49%

CDNACAREDX INC

3.38%

VCYTVERACYTE INC

2.66%

CMPSCOMPASS PATHWAYS PLC

2.43%

Sectors

1Health Care

85%

2Information Technology

3Industrials

4Unclassified

Geography

1United States

91%

2Switzerland

3Unclassified

Hold ARKG alongside other funds? See your combined true holdings, overlap, and blended fees — free, no signup.

Unwrap your portfolio →

Data source: official SEC Form N-PORT filings (as of 2026-04-30); expense ratio from SEC prospectus (risk/return) filings. Fund holdings are disclosed quarterly and may reflect a 60-day reporting delay.
Informational and educational only — not investment advice.